No beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infection.

F. N. Lauw; J. T. van Der Meer; J. de Metz; S. A. Danner; T. van Der Poll

doi:10.1086/318705

No beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infection.

F. N. Lauw^*
, J. T. van Der Meer
, J. de Metz
, S. A. Danner
, T. van Der Poll

^*Corresponding author for this work

University of Amsterdam

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Two human immunodeficiency virus-infected patients with refractory disseminated Mycobacterium avium complex infection were treated with recombinant interferon-gamma (IFN-gamma) given subcutaneously for 3 and 4 months, respectively. Although both patients demonstrated some clinical improvement initially, IFN-gamma therapy did not produce sustained benefit.

Original language	English
Pages (from-to)	e81-82
Journal	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume	32
Issue number	4
DOIs	https://doi.org/10.1086/318705
Publication status	Published - 15 Feb 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1086/318705

Cite this

Lauw, F. N., van Der Meer, J. T., de Metz, J., Danner, S. A., & van Der Poll, T. (2001). No beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 32(4), e81-82. https://doi.org/10.1086/318705

@article{520d6418c07d4fb1aebecc689921b6ef,

title = "No beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infection.",

abstract = "Two human immunodeficiency virus-infected patients with refractory disseminated Mycobacterium avium complex infection were treated with recombinant interferon-gamma (IFN-gamma) given subcutaneously for 3 and 4 months, respectively. Although both patients demonstrated some clinical improvement initially, IFN-gamma therapy did not produce sustained benefit.",

author = "Lauw, \{F. N.\} and \{van Der Meer\}, \{J. T.\} and \{de Metz\}, J. and Danner, \{S. A.\} and \{van Der Poll\}, T.",

year = "2001",

month = feb,

day = "15",

doi = "10.1086/318705",

language = "English",

volume = "32",

pages = "e81--82",

journal = "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",

issn = "1058-4838",

number = "4",

}

Lauw, FN, van Der Meer, JT, de Metz, J, Danner, SA & van Der Poll, T 2001, 'No beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infection.', Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 32, no. 4, pp. e81-82. https://doi.org/10.1086/318705

No beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infection. / Lauw, F. N.; van Der Meer, J. T.; de Metz, J. et al.
In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 32, No. 4, 15.02.2001, p. e81-82.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - No beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infection.

AU - Lauw, F. N.

AU - van Der Meer, J. T.

AU - de Metz, J.

AU - Danner, S. A.

AU - van Der Poll, T.

PY - 2001/2/15

Y1 - 2001/2/15

N2 - Two human immunodeficiency virus-infected patients with refractory disseminated Mycobacterium avium complex infection were treated with recombinant interferon-gamma (IFN-gamma) given subcutaneously for 3 and 4 months, respectively. Although both patients demonstrated some clinical improvement initially, IFN-gamma therapy did not produce sustained benefit.

AB - Two human immunodeficiency virus-infected patients with refractory disseminated Mycobacterium avium complex infection were treated with recombinant interferon-gamma (IFN-gamma) given subcutaneously for 3 and 4 months, respectively. Although both patients demonstrated some clinical improvement initially, IFN-gamma therapy did not produce sustained benefit.

UR - https://www.scopus.com/pages/publications/18044404841

U2 - 10.1086/318705

DO - 10.1086/318705

M3 - Article

C2 - 11181141

SN - 1058-4838

VL - 32

SP - e81-82

JO - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

IS - 4

ER -

No beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infection.

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this